PIK3C3 (VPS34) Protein

Introduction

PIK3C3, also known as VPS34 (Vacuolar Protein Sorting 34), is the catalytic subunit of the sole class III phosphoinositide 3-kinase (PI3K) in mammals. It plays a central and essential role in autophagy and endosomal trafficking by phosphorylating phosphatidylinositol to produce phosphatidylinositol 3-phosphate (PI3P) ^{1VPS34 PI3-kinase function (2016)2016 · PMID 26885861Open reference}. Unlike class I PI3Ks that regulate cell growth and survival, PIK3C3 is dedicated to membrane trafficking and organelle homeostasis, making it critical for neuronal function and survival.

The discovery that PIK3C3 variants cause neurodegenerative disorders, including hereditary spastic paraplegia, cerebellar atrophy, and atypical parkinsonism, has highlighted its importance in the central nervous system ^{2PIK3C3 in Parkinson's disease (2020)2020 · Frontiers in Immunology · DOI 10.3389/fimmu.2020.00239 · PMID 32054288Open reference}. PIK3C3 dysfunction contributes to the pathogenesis of Alzheimer’s disease, Parkinson’s disease, and amyotrophic lateral sclerosis through impaired autophagic clearance of protein aggregates and damaged organelles ^{3Autophagy in neurodegeneration (2019)2019 · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · DOI 10.1016/j.biopha.2018.11.143 · PMID 30673643Open reference}.

The discovery that PIK3C3 variants cause neurodegenerative disorders, including hereditary spastic paraplegia, cerebellar atrophy, and atypical parkinsonism, has highlighted its importance in the central nervous system ^{2PIK3C3 in Parkinson's disease (2020)2020 · Frontiers in Immunology · DOI 10.3389/fimmu.2020.00239 · PMID 32054288Open reference}. PIK3C3 dysfunction contributes to the pathogenesis of Alzheimer’s disease, Parkinson’s disease, and amyotrophic lateral sclerosis through impaired autophagic clearance of protein aggregates and damaged organelles ^{3Autophagy in neurodegeneration (2019)2019 · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · DOI 10.1016/j.biopha.2018.11.143 · PMID 30673643Open reference}.

Gene and Protein Structure

Gene Organization

The human PIK3C3 gene is located on chromosome 18q12.3 and spans approximately 30 kb. It consists of 32 exons that encode the 887-amino acid PIK3C3 protein. Multiple transcript variants are produced through alternative splicing, with the canonical isoform (Isoform 1) being the predominant form in neuronal tissue.

Protein Domain Architecture

PIK3C3 adopts a characteristic phosphatidylinositol 3-kinase domain architecture ^{4BCG Vaccination Protects against Experimental Viral Infection in Humans through the Induction of Cytokines Associated with Trained Immunity.2018 · Cell host & microbe · DOI 10.1016/j.chom.2017.12.010 · PMID 29324233Open reference}:

N-terminal Helical Domain (aa 1-150): This domain mediates interaction with the regulatory subunit VPS15 and facilitates proper subcellular localization. It contains a unique region that directs the protein to autophagosomes and endosomes.

C2 Domain (aa 200-320): The C2 domain targets PIK3C3 to membrane surfaces by binding phospholipids in a calcium-independent manner. This domain is critical for recruitment to isolation membranes during autophagosome biogenesis.

Kinase Domain (aa 400-887): The catalytic domain phosphorylates the 3-hydroxyl group of phosphatidylinositol (PI) and phosphatidylinositol 4-phosphate (PI4P), though PI is the preferred substrate. The kinase domain contains the activation loop and P-loop motifs essential for ATP binding and catalysis.

Structural Insights

Crystal and cryo-EM structures of PIK3C3 have revealed:

• A “U-shaped” conformation where the N-terminal domains fold back onto the kinase domain

• A membrane-interacting surface that orient the active site toward the lipid bilayer

• Multiple regulatory phosphorylation sites that modulate activity

Biological Functions

Autophagy Initiation

PIK3C3/VPS34 is the master regulator of autophagy initiation ^{5Citation2016}:

PI3P Production: PIK3C3 generates PI3P on the surface of the isolation membrane (phagophore), the precursor to the autophagosome. This lipid modification is the defining feature of nascent autophagosomes and is essential for their formation.

PI3P Effectors: PI3P recruits multiple autophagy proteins including WIPI1, WIPI2, DFCP1, and ATG14. These proteins coordinate the recruitment of the ATG12-ATG5-ATG16L1 conjugation system, which mediates lipidation of LC3 (MAP1LC3A).

Autophagosome Formation: PIK3C3 activity is required for the nucleation and expansion of the autophagosome. Without PI3P production, the isolation membrane cannot form properly, and autophagosome biogenesis fails.

Endosomal Trafficking

Beyond autophagy, PIK3C3 regulates endosomal maturation and sorting ^{6VPS34 and lysosomal trafficking (2006)2006 · PMID 16493418Open reference}:

Endosomal Maturation: PIK3C3-generated PI3P is required for the conversion of early endosomes to late endosomes. This involves the recruitment of the HOPS complex, which mediates tethering and fusion with lysosomes.

Cargo Sorting: PI3P on endosomal membranes directs the sorting of cargo for degradation or recycling. Defects in this process lead to the accumulation of endosomal vesicles and impaired nutrient recycling.

Lysosomal Function: PIK3C3 contributes to lysosomal biogenesis and function through its role in autophagosome-lysosome fusion. The protein interacts with the HOPS complex via VPS34-generated PI3P.

Regulatory Mechanisms

Multiple mechanisms regulate PIK3C3 function:

Complex Formation: PIK3C3 functions as part of a heterotetrameric complex with VPS15 (p150), VPS30/Beclin 1, and either ATG14 or UVRAG. This association is essential for its stability and activity.

Phosphorylation: VPS15 phosphorylates PIK3C3 at multiple sites, enhancing its activity. Additional kinases including AMPK and mTOR regulate PIK3C3 indirectly through the upstream autophagy machinery.

Lipid Regulation: PIK3C3 activity is modulated by membrane lipid composition. Phosphatidic acid and other lipids can activate PIK3C3, while certain phosphoinositides inhibit its activity.

Role in Neurodegenerative Diseases

Parkinson’s Disease

PIK3C3 dysfunction is increasingly recognized as a contributor to PD pathogenesis ^{7BMAL1-Downregulation Aggravates Porphyromonas Gingivalis-Induced Atherosclerosis by Encouraging Oxidative Stress.2020 · Circulation research · DOI 10.1161/CIRCRESAHA.119.315502 · PMID 32078488Open reference}:

Genetic Evidence:

• PIK3C3 variants have been identified in families with atypical parkinsonism

• Mutations cause hereditary spastic paraplegia with parkinsonian features

• Reduced PIK3C3 expression in PD brains correlates with disease severity

Autophagy Impairment:

• Impaired PIK3C3 activity leads to accumulation of alpha-synuclein aggregates

• Mitophagy defects result in accumulation of dysfunctional mitochondria

• Reduced autophagic flux in dopaminergic neurons

VPS35 Interaction: VPS35, a component of the retromer complex, directly interacts with PIK3C3 pathway components ^{8Shaping action sequences in basal ganglia circuits2015 · Current Opinion in Neurobiology · DOI 10.1016/j.conb.2015.06.011 · PMID 26189204Open reference}. VPS35 mutations (D620N) cause familial PD and impair endosomal trafficking and autophagy.

Therapeutic Implications:

• Enhancing PIK3C3 activity may improve alpha-synuclein clearance

• Gene therapy approaches to restore PIK3C3 expression under investigation

• Small molecule activators of the class III PI3K pathway in development

Alzheimer’s Disease

PIK3C3 contributes to AD pathogenesis through multiple mechanisms ^{2PIK3C3 in Parkinson's disease (2020)2020 · Frontiers in Immunology · DOI 10.3389/fimmu.2020.00239 · PMID 32054288Open reference}0:

Amyloid Metabolism:

• PIK3C3 dysfunction impairs autophagic clearance of amyloid precursor protein (APP) processing products

• Autophagic vacuoles accumulate in AD brains due to impaired clearance

• PI3P deficiency affects synaptic function and plasticity

Tau Pathology:

• Autophagy impairment contributes to tau aggregation

• PIK3C3 activity is reduced in AD hippocampus

• Restoring autophagy may reduce tau pathology

Synaptic Dysfunction:

• Autophagy is essential for synaptic homeostasis

• PIK3C3 deficiency leads to synaptic protein accumulation

• Impaired organelle turnover affects neuronal survival

Amyotrophic Lateral Sclerosis and Frontotemporal Dementia

PIK3C3 dysfunction contributes to ALS/FTD pathogenesis ^{2PIK3C3 in Parkinson's disease (2020)2020 · Frontiers in Immunology · DOI 10.3389/fimmu.2020.00239 · PMID 32054288Open reference}1:

TDP-43 Pathology:

• TDP-43 aggregation impairs autophagic flux

• PIK3C3 expression reduced in ALS motor neurons

• Restoring autophagy may ameliorate TDP-43 pathology

Protein Aggregate Clearance:

• Impaired autophagosome formation leads to protein aggregate accumulation

• Defects in lysosomal function compound the problem

• Mutations in other autophagy genes (e.g., TBK1, OPTN) interact with PIK3C3 pathway

Therapeutic Potential:

• Enhancing PIK3C3 activity as a therapeutic strategy

• Combination approaches targeting multiple steps of autophagy

• Gene therapy to restore PIK3C3 expression

Signaling Pathways

Autophagy-Lysosome Pathway

PIK3C3 functions at the apex of the autophagy pathway:

1. Nucleation: PIK3C3 generates PI3P on isolation membranes

2. Expansion: PI3P recruits autophagy proteins for membrane expansion

3. Closure: The autophagosome closes, encapsulating cargo

4. Fusion: The autophagosome fuses with lysosomes for degradation

Endosomal-Lysosomal System

PIK3C3 regulates the endosomal-lysosomal network:

1. Early Endosome Formation: PI3P on endocytic vesicles

2. Maturation: Conversion to late endosomes requires PIK3C3

3. Sorting: Cargo is directed to lysosomes or recycled

4. Fusion: HOPS-mediated fusion with lysosomes

Therapeutic Approaches

Small Molecule Activators

Drug discovery efforts target PIK3C3 activation:

• Direct PIK3C3 activators in development

• Indirect autophagy enhancers that increase PIK3C3 activity

• Combination therapies with lysosomal modulators

Gene Therapy

Viral vector delivery of PIK3C3 shows promise:

• AAV-mediated gene delivery in preclinical models

• Restoration of autophagic flux in neurons

• Improvement in animal models of neurodegeneration

Target Validation

Clinical validation of PIK3C3 as a therapeutic target:

• Genetic evidence from patients with PIK3C3 variants

• Animal models showing benefit with enhanced PIK3C3 activity

• Biomarker development for patient selection

Research Methods

Study of PIK3C3 employs various techniques:

• Biochemistry: In vitro kinase assays, lipid mass spectrometry, co-immunoprecipitation

• Cell Biology: Live-cell imaging of autophagosome formation, FRAP, super-resolution microscopy

• Genetics: Knockout mice, CRISPR, patient-derived iPSCs

• Structural Biology: Cryo-EM of PIK3C3 complexes

• Metabolomics: Lipid profiling to assess PI3P levels

Animal Models

Knockout Mice

Pik3c3 Null Mice:

• Embryonic lethal phenotypes

• Severe autophagy defects

• Accumulation of protein aggregates

Conditional Knockouts:

• Neuron-specific deletion causes neurodegeneration

• Impaired autophagic flux in大脑

• Behavioral deficits similar to neurodegenerative disease

Transgenic Models

Pik3c3 Overexpression:

• Enhanced autophagic flux

• Reduced protein aggregate accumulation

• Protection against neurotoxic insults

Pathway & Interaction Diagram

Interactive diagram showing PIK3C3’s key relationships in the SciDEX knowledge graph (15 connections shown).

flowchart TD
    PIK3C3(["PIK3C3"])
    autophagy["autophagy"]
    PARKINSON_S_DISEASE(["PARKINSON'S DISEASE"])
    BECN1(["BECN1"])
    BRSK2(["BRSK2"])
    AUTOPHAGY["AUTOPHAGY"]
    Metabolic_Syndrome["Metabolic Syndrome"]
    Ischemia["Ischemia"]
    Ms["Ms"]
    Cancer["Cancer"]
    Als["Als"]
    Fibrosis["Fibrosis"]
    Tumor["Tumor"]
    Parkinson["Parkinson"]

    PIK3C3 -->|"activates"| autophagy
    PIK3C3 -->|"associated with"| PARKINSON_S_DISEASE
    BECN1 -->|"associated with"| PIK3C3
    BRSK2 -->|"associated with"| PIK3C3
    PIK3C3 -->|"regulates"| AUTOPHAGY
    PIK3C3 -->|"activates"| Metabolic_Syndrome
    PIK3C3 -->|"regulates"| Ischemia
    PIK3C3 -->|"regulates"| Ms
    PIK3C3 -->|"interacts with"| Cancer
    PIK3C3 -->|"interacts with"| Als
    PIK3C3 -->|"interacts with"| Ms
    PIK3C3 -->|"interacts with"| Fibrosis
    PIK3C3 -->|"associated with"| Tumor
    PIK3C3 -->|"associated with"| Parkinson
    PIK3C3 -->|"associated with"| Cancer

    style PIK3C3 fill:#006494,stroke:#4fc3f7,stroke-width:3px,color:#e0e0e0

See Also

• PIK3C3 Gene

• Autophagy Pathway

• Parkinson’s Disease

• Alzheimer’s Disease

• VPS35 Protein

• Beclin 1 Protein

• Alpha-Synuclein

• Tau Protein

External Links

• UniProt: Q8N3F7 - PIK3C3

• NCBI Gene: PIK3C3

• GeneCards: PIK3C3

• AlphaFold: PIK3C3

• KEGG: mTOR signaling pathway